Renz Justin A
Zevra Therapeutics, Inc. · CFO
Renz Justin A is listed in filings as CFO at Zevra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to Zevra Therapeutics, Inc. (ZVRA) and Ardelyx, Inc. (ARDX). The current snapshot covers public activity from Aug 22, 2024 to Mar 19, 2026. Reported amounts are shown as $2.9M to $29.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $29k7.2k shares | SellMay 20, 2025 | $4.08 | $5.54 | |
| $29k5.2k shares | SellFeb 20, 2025 | $5.62 | $5.54 | |
| $25k5.3k shares | SellNov 20, 2024 | $4.79 | $5.54 | |
| $31k5.3k shares | SellAug 20, 2024 | $5.86 | $5.54 |